Select Page
Responsive Centered YouTube Video
Understanding the implications of Spike protein accumulation in the body and the need for detoxification.
  • Spike protein presence in the body can lead to serious health implications. 5:04

  • Detoxification of Spike protein is crucial to eliminate microclots. 5:46

  • Spike protein fragments can remain in the body for an extended period. 6:49

  • Over 90% of Spike protein is found stuck in cells rather than circulating in the blood. 7:05

  • Pathological examinations reveal Spike protein accumulation in delicate parts of the body. 7:31

  • The distribution of Spike protein in the body occurs through various injection methods. 8:04

  • Neurological symptoms and microclotting may be linked to Spike protein accumulation. 8:40

Understanding the distribution and impact of Spike protein in the body through pre-clinical trials.
  • Spike protein shows wide distribution in different tissues post-exposure. 8:47

  • Animal models provide insights into human distribution and pathology correlation. 9:11

  • Lab testing with fluorescent dye confirms widespread distribution of Spike protein. 12:11

  • Pathological exams reveal high levels of Spike in critical areas like the brain and cardiovascular system. 14:42

  • Endothelial cells are identified as key sites for Spike protein accumulation. 15:05

Understanding the harmful effects of Spike protein accumulation in the body and the importance of detoxification.
  • Spike protein in the body can lead to the creation of toxic amyloidogenic and thrombogenic fibers. 15:13

  • The spike protein from both infection and vaccination can cause significant damage. 17:04

  • Kidneys are particularly susceptible to spike protein damage, leading to inflammation and dysfunction. 18:46

  • Pathological examinations show widespread accumulation of Spike protein in endothelial cells, impacting blood flow and causing neurological symptoms. 20:03

  • Vaccine Spike can spread through the bloodstream, leading to prolonged production of Spike protein. 21:25

Understanding the Impact of Spike Protein on Neurodegenerative Diseases
  • Spike protein functions by binding to cells and spreading throughout the organism, leading to long-term attachment to various cells. 22:05

  • Once inside a cell, the spike protein disrupts internal mechanisms and blocks degradation or removal processes. 23:04

  • The spike protein does not replicate but accumulates within the cell, causing significant disruptions. 23:13

  • Spike protein impacts the blood-brain barrier, leading to increased permeability and neurodegenerative disease acceleration. 25:01

  • The presence of spike protein in the brain periphery results in severe neurodegenerative developments and brain inflammation. 27:03

  • Neurological complications such as dementia may be exacerbated by the effects of spike protein and viral infections. 28:13

Understanding the potential long-term effects of Spike protein exposure and the challenges in detoxification.
  • Presentation on liver diseases and potential mechanisms 0:08
  • Fatty liver prevalence and its link to insulin resistance 1:29
  • Focus on alcohol liver disease, fatty liver, and liver injury 2:05
  • Importance of recognizing liver health for overall well-being 2:36
  • Risk of harm from multiple factors affecting liver function 2:54
Exploring strategies for detoxifying spike protein and enhancing cell health.
  • Intermittent fasting and senolytics may help reduce spike protein in cells. 35:09

  • Senolytics can break down senescent cells harboring spike protein or virus remnants. 35:23

  • Using binders alongside senolytics can ensure effective binding to spike protein debris. 39:37

  • Various molecules with high binding affinity to spike protein are being utilized for detoxification. 41:22

Understanding the Impact of Spike Protein on Health and the Importance of Early Detection
  • Sulfated polysaccharides like Heparin and Heparin sulfate are effective in binding to spike proteins for removal. 41:46

  • New molecules are four times more efficient than Heparin in binding to spike proteins. 42:01

  • Various host cell receptors need to be blocked to prevent spike protein attachment. 42:32

  • Products have shown effectiveness in blocking host cell receptors like Axland, DPP4, and NP1. 43:07

  • Furin, TMPRSS2, and Trin enzymes facilitating spike entry into cells also need to be targeted. 43:13

  • Microthrombi testing reveals high levels in individuals post-COVID or vaccination, indicating potential health risks. 44:55

  • Biochemical abnormalities and biomarker changes suggest widespread impact of spike protein exposure. 45:55

  • Early proactive intervention based on biochemical findings is crucial to prevent clinical manifestations. 47:31

  • Specific tests for quantifying risks associated with spike protein exposure are essential for targeted treatments. 48:15

Insights on biomarkers, clinical presentations, and spike protein detox in patients post-exposure.
  • Various biomarkers like CRPs, interleukins, and D-dimers show abnormalities in post-exposure patients. 48:39

  • Unique clinical presentations observed in patients, including microclots and abnormal blood pictures. 49:39

  • Importance of understanding immune response to spike protein for diagnosis and treatment. 50:09

  • Markers like EBV reactivation, low white blood cell count, and AA 42/40 ratio play a role in patient evaluation. 50:32

  • Significance of TGF beta-1 elevation and beta amylo production in assessing post-exposure issues. 51:08

  • Spike detox protocol shows promise in reducing microclots and endothelitis in patients. 53:37

  • Removing spike protein is crucial in managing microclots and improving endothelial health. 55:06

Understanding the impact of Spike protein on long-term health and detox strategies.
  • Spike protein production in immune cells poses challenges in switching them off. 55:32

  • Strategies like using steroids aim to reboot the immune system to eliminate Spike protein source. 55:49

  • Targeting cells producing Spike protein with senolytics to address immunosenescence. 56:30

  • Case study of a long COVID patient showing biomarker improvements after treatment protocol. 1:00:09

  • Treatment combining medicinals, Riso health, transvers vitrol, and senolytics led to biomarker normalization. 1:00:17

  • Positive outcomes observed in patients after 6-8 weeks of therapy, with some requiring retreatment for sustained stability. 1:01:11

  • Long-term stability seen in patients post-treatment, indicating effectiveness of the protocol. 1:01:19

Insights on addressing persistent viral infections and autoimmunity related to spike protein detox.
  • Persistent viral infections may result from not fully addressing the spike protein root cause. 1:01:52

  • Patients may initially feel better with treatment, but relapse occurs if the spike protein is not completely eliminated. 1:01:59

  • Tapering medications without addressing the spike protein can lead to rebound symptoms. 1:02:19

  • Some individuals may be predisposed to developing conditions related to spike protein toxicity. 1:03:54

  • Infections primarily enter through the nose, making nasal sprays a valuable prophylactic approach. 1:05:19

  • Detoxification is crucial before focusing on other therapeutic interventions for long-hauler patients. 1:06:02

  • Delay in addressing the spike protein can lead to autoimmune reactions targeting cells presenting spike proteins. 1:07:01

  • A significant portion of the population may struggle to control viral infections, leading to persistent infection. 1:08:03

Understanding the impact of liver diseases and potential mechanisms in managing them
  • Presentation on liver diseases and potential mechanisms 0:08

  • Fatty liver prevalence and its link to insulin resistance 1:29

  • Focus on alcohol liver disease, fatty liver, and liver injury 2:05

  • Importance of recognizing liver health for overall well-being 2:36

  • Risk of harm from multiple factors affecting liver function 2:54

Understanding the challenges of detoxifying from Spike protein exposure and the importance of addressing kidney damage.
  • Spike protein exposure is a significant concern, both from the virus and vaccines. 1:08:34

  • Patients may experience immunologic responses to Spike protein, leading to various symptoms. 1:09:12

  • Detox process varies for individuals with renal or liver issues, caution needed in breaking down Spike protein. 1:09:51

  • Kidney injury is a growing issue due to Spike protein exposure, alternative routes for excretion need consideration. 1:10:56

  • Humic acid from Germany shows potential in binding and eliminating Spike protein in the gut. 1:12:14

  • Coratin has shown effectiveness in preventing Spike protein damage in kidney cells. 1:13:25

  • Ensuring high levels of pure coratin in the bloodstream is crucial for its efficacy in trials. 1:14:06

  • Combining various molecules and chelators can aid in blocking Spike protein activity and detoxification. 1:14:19

  • Specialized kidney and gut restoration protocols are being developed to address Spike protein detoxification challenges. 1:14:26

Holistic approach to treating complex diseases with nutraceuticals and detox pathways.
  • Holistic approach integrating nutraceuticals for multisystemic diseases. 1:14:39

  • Utilizing natural compounds to target multiple biochemical pathways simultaneously. 1:16:09

  • Challenges of pharmaceuticals in addressing broad disease pathways. 1:18:01

  • Importance of education on nutraceuticals’ efficacy and research. 1:18:27

  • Hope for success in treating complex diseases with holistic methods. 1:19:39

  • Integration of holistic approaches in modern medicine for better outcomes. 1:19:56

  • Addressing environmental factors in disease management and prevention. 1:20:24

  • Challenges in understanding and treating the disease within the healthcare community. 1:20:56

  • Positive outcomes and patient recovery with dedicated treatment approaches. 1:21:12

Insights on ongoing exposure to pathophysiological drivers, preventative measures, and hope from medical experts.
  • Learning more about pathophysiological drivers to find preventative solution. 1:21:29

  • Hope and support from medical experts and scientist. 1:21:42

  • Success with patients and ongoing efforts to bring back healt. 1:21:57

  • Future development of roots to restore population healt. 1:22:06

  • Acknowledgment of the start of the pandemic impac. 1:22:22

  • Acknowledgment of the long road ahead in dealing with the pandemic impac. 1:22:22

  • Importance of finding solutions for patients worldwid. 1:22:29

  • Gratitude for the educational session and anticipation of future presentation. 1:22:36